bezafibrate

Bezafibrate (BM15075) is an antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW-DENSITY LIPOPROTEINS and increases HIGH-DENSITY LIPOPROTEINS.

Bezafibrate-D6 (dimethyl-D6) is a deuterated compound of Bezafibrate. Bezafibrate (T0841) has a CAS number of 41859-67-0. Bezafibrate (T0841) is an antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW-DENSITY LIPOPROTEINS and increases HIGH-DENSITY LIPOPROTEINS.

Bezafibrate (Standard) is the standard substance of Bezafibrate, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Bezafibrate (BM15075) is an antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW-DENSITY LIPOPROTEINS and increases HIGH-DENSITY LIPOPROTEINS.

Bezafibrate-D6 (Dimethyl-D6) (Standard) is a reference standard of Bezafibrate-D6 (Dimethyl-D6) intended for quantitative analysis, quality control, and related biochemical research applications. Bezafibrate-d6 (dimethyl-d6) is a deuterated compound of Bezafibrate. Bezafibrate has a CAS number of 41859-67-0. Bezafibrate is an antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW-DENSITY LIPOPROTEINS and increases HIGH-DENSITY LIPOPROTEINS.

RXR antagonist 6 (Compound 34) is a selective partial antagonist of the retinoid X receptor (RXR). It exhibits no agonistic activity on human RXRα/β/γ subtypes, but it effectively inhibits receptor activation induced by full RXR agonists such as Bezafibrate, with an IC50 value of 2.7 μM. Additionally, RXR antagonist 6 can enhance PMA-induced differentiation of THP-1 cells and is applicable in research related to cancer, metabolic disorders, and neurological diseases, including lymphoma.